Dartmouth Cancer Center
Amber Barrows
One Medical Center Drive
Lebanon, NH 03756
https://cancer.dartmouth.edu/scientists-researchers/pathology-shared-resource
RRID: RRID:SCR_023479
Assay Development
Clinical Trial Support
Immunohistochemistry
Staining
Tissue Embed
Tissue MicroArray
Whole Slide Imaging
1.) Costa FD, Alves de Castro JV, Gomes YM, Kulikowski LD, Wolff B, Gregianin LJ, Scapulatempo Neto C, Al Dalahmah O, Canoll PD, Bruce JN, Aldape K, Abdullaev Z, Nasrallah MP, Alex-Wele C, Palisoul S, Zanazzi G, Sadanandappa MK (2025 Sep 9). Pineal region high-grade neuroepithelial tumors with NTRK fusions map to the novel methylation class "diffuse high-grade glioma, IDH-wild type, subtype E". Acta neuropathologica, 150(1), 26. doi: 10.1007/s00401-025-02934-y. PMID: 40926036.
2.) Tau S, Friedman M, Roberts AM, Ferridge LR, Kleist SA, Cressey L, Kettenbach AN, Shoemaker CJ, Miller TW (2025 Jul 23). Endocrine therapy induces oxidative stress in ER+ breast cancer that sensitizes persister cells to ferroptosis. bioRxiv : the preprint server for biology, (), . . PMID: 40777469.
3.) Jakubzick C, Ghosh S, Li X, Rawat K, Dighal A, Kalinowski S, Knolling F 4th, Ringelberg C (2025 Jul 4). The Dichotomy of Tumor Control by Recruited and Resident Tumor-Associated Macrophages. Research square, (), . . PMID: 40630529.
4.) Johnson AL, Tau S, Sloop AM, Dai T, Roberts AM, Muskus P, Warren A, Kleist SA, Hampsch RA, Jorns JM, Zhang R, Jarvis LA, Miller TW (2025 Jun 9). Combined Radiation and Endocrine Therapies Elicit Benefit in ER+ Breast Cancer. Cancers, 17(12), . . PMID: 40563571.
5.) Robins SM, Rosenblatt M, Bruce JN, Canoll P, Zanazzi G (2025 May 1). Solitary fibrous tumor in the pineal region: A series of 5 cases and literature review. Journal of neuropathology and experimental neurology, 84(5), 379-390. . PMID: 39950237.
6.) Tau S, Chamberlin MD, Yang H, Marotti JD, Muskus PC, Roberts AM, Carmichael MM, Cressey L, Dragnev CPC, Demidenko E, Hampsch RA, Soucy SM, Kolling FW, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW (2025 Mar 14). Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer. Cancer research, 85(6), 1145-1161. . PMID: 39777474.
7.) Tau S, Chamberlin MD, Yang H, Marotti JD, Roberts AM, Carmichael MM, Cressey L, Dragnev C, Demidenko E, Hampsch RA, Soucy SM, Kolling F, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW (2024 Sep 27). Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation. bioRxiv : the preprint server for biology, (), . . PMID: 39386444.
8.) Jones VM, Thompson LDR, Pettus JR, Green DC, Lefferts JA, Shah PS, Tsongalis GJ, Sajed DP, Guilmette JM, Lewis JS, Fisch AS, Tafe LJ, Kerr DA (2024 Sep 8). Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study. Research square, (), . . PMID: 39281855.
9.) Bentz JL, Barney RE, Georgantzoglou N, Manxhuka-Kerliu S, Ibishi VA, Dacaj-Elshani B, Bejarano S, Palumbo PE, Suresh A, LaRochelle EPM, Keegan WP, Wilson TL, Dokus BJ, Hershberger KC, Gallagher TL, Allen SF, Palisoul SM, Steinmetz HB, Kennedy LS, Tsongalis GJ (2024 Aug 19). High-Risk HPV Screening Initiative in Kosovo-A Way to Optimize HPV Vaccination for Cervical Cancer. Diseases (Basel, Switzerland), 12(8), . . PMID: 39195188.
10.) Bagheri M, Lee MK, Muller KE, Miller TW, Pattabiraman DR, Christensen BC (2024 Mar). Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics, 16(5), 293-308. . PMID: 38356412.
11.) Traphagen NA, Schwartz GN, Tau S, Roberts AM, Jiang A, Hosford SR, Marotti JD, Goen AE, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW (2023 Sep 15). Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(18), 3717-3728. . PMID: 37439680.
12.) Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW (2023 Aug 1). Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(15), 2767-2773. . PMID: 37260292.
Dartmouth-Hitchcock Medical Center / Geisel School of Medicine
